Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-1999 | |
| Cash Flows From Operating Activities | |
| Net Income | 4,281 |
| Depreciation Amortization | 448 |
| Income taxes - deferred | 322 |
| Accounts receivable | 4,083 |
| Accounts payable and accrued liabilities | -1,248 |
| Other Working Capital | 1,766 |
| Other Operating Activity | -2,835 |
| Operating Cash Flow | $6,817 |
| Cash Flows From Investing Activities | |
| PPE Investments | -77 |
| Net Acquisitions | -4,598 |
| Investing Cash Flow | $-4,675 |
| Cash Flows From Financing Activities | |
| Common Stock Issued | 41 |
| Financing Cash Flow | $41 |
| Beginning Cash Position | 1,317 |
| End Cash Position | 3,500 |
| Net Cash Flow | $2,183 |
| Free Cash Flow | |
| Operating Cash Flow | 6,817 |
| Capital Expenditure | -77 |
| Free Cash Flow | 6,740 |